Synexus Magyarország Kft.
About Synexus Magyarország Kft.
"A Synexus rendelők klinikai kutatásokra szakosodott vizsgálóhelyek, amelyek már több mint 20 éve vizsgálják az új gyógyszerek és kezelések hatékonyságát. Barátságos, nyugodt környezetet biztosítunk, ahol közösen hozzájárulhatunk Ön és mások egészségi állapotának javulásához, valamint a jövő nemzedék gyógyszereinek megszületéséhez. Jelenleg négy saját rendelőnk és két partneri vizsgálóhelyünk van Magyarországon, és további 34 saját klinikánk szerte a világon. Mindegyik magasan képzett orvosi és nővéri csapattal rendelkezik, hogy biztosítsuk betegeink számára a legmagasabb kényelmet és a professzionalizmust, mely általában megtalálható a magán egészségügyi szolgáltatásban."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
12
Gilead Sciences
4
Amgen
3
Boehringer Ingelheim
3
Bristol-Myers Squibb
2
Eli Lilly and Company
2
Hoffmann-La Roche
2
Janssen Research & Development, LLC
2
Merck Sharp & Dohme LLC
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
Phathom Pharmaceuticals, Inc.
2
Clinical Trials at Synexus Magyarország Kft.
During the past decade, Synexus Magyarország Kft. conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 26 clinical trials were completed, i.e. on
average, 104% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 12 clinical trials were completed. i.e. 240%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee
2007-11-01
2011-11-01
Completed
1,457
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
2008-06-01
Completed
317
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women
2009-06-01
2011-02-01
Completed
565
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
2010-01-01
2013-03-01
Completed
956
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
2010-08-01
2011-07-01
Completed
1,013
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
2010-09-01
2016-06-01
Terminated
2,867
Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)
2010-10-01
2013-11-01
Completed
109
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Synexus Magyarország Kft." #1 sponsor was "Pfizer" with 12 trials, followed by "Gilead Sciences" with 4 trials
sponsored, "Amgen" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Bristol-Myers Squibb"
with 3 trials sponsored. Other sponsors include 21 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus Magyarország Kft."
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Synexus Magyarország Kft.
According to Clinical.Site data, the most researched conditions in "Synexus Magyarország Kft." are
"Psoriasis" (6 trials), "Psoriatic Arthritis" (4 trials), "Crohn's Disease" (3 trials), "Diabetes Mellitus, Type 2" (3 trials) and "Type 2 Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Synexus Magyarország Kft." in a lesser frequency.
Clinical Trials Intervention Types at Synexus Magyarország Kft.
Most popular intervention types in "Synexus Magyarország Kft." are "Drug" (48 trials), "Behavioral" (3 trials), "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "CP-690,550" (3 trials), "Diet" (3 trials), "Exercise" (3 trials) and "Ranolazine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Synexus Magyarország Kft.
The vast majority of trials in "Synexus Magyarország Kft." are
47 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Synexus Magyarország Kft.
Currently, there are NaN active trials in "Synexus Magyarország Kft.".
undefined are not yet recruiting,
1 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 36 completed trials in Synexus Magyarország Kft.,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Synexus Magyarország Kft., 0 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 0 trials that are defined as “Not Applicable".